Industry Roundup
This article was originally published in The Tan Sheet
Executive Summary
PowerBar plant closing; Medifast, investor agree on board changes; BioPharmX announces IPO; Mérieux expands southeast U.S. testing; more news in brief.
You may also be interested in...
Omega-3 Petition Seeks Unqualified Blood Pressure, CHD Claims
The trade group Global Organization for EPA and DHA Omega-3 petitions FDA for an unqualified health claim related to reduced blood pressure as a surrogate marker for coronary heart disease risk.
In Brief
FDA finalizes OTC dosing guidance
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”